Carsten Köhler Selected Research

Mass Drug Administration

1/2022	Onchocerca volvulus-specific antibody and cellular responses in onchocerciasis patients treated annually with ivermectin for 30 years and exposed to parasite transmission in central Togo.
1/2020	Ivermectin for causal malaria prophylaxis: a randomised controlled human infection trial.
1/2018	Onchocerca volvulus infection and serological prevalence, ocular onchocerciasis and parasite transmission in northern and central Togo after decades of Simulium damnosum s.l. vector control and mass drug administration of ivermectin.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Carsten Köhler Research Topics

Disease

10	Infections 01/2023 - 07/2003
9	Malaria 05/2021 - 07/2003
3	Parasitic Diseases (Parasitic Disease) 01/2022 - 01/2015
3	Intestinal Volvulus (Volvulus) 01/2022 - 01/2018
2	COVID-19 01/2023 - 05/2021
2	Alveolar echinococcosis 02/2022 - 02/2018
2	Onchocerciasis 01/2022 - 01/2018
2	Parasitemia 01/2021 - 01/2012
2	Inflammation (Inflammations) 01/2016 - 01/2015
1	Communicable Diseases (Infectious Diseases) 05/2021
1	Tuberculosis (Tuberculoses) 05/2021
1	Coinfection 05/2018
1	Neoplasms (Cancer) 02/2018
1	Ocular Onchocerciasis (River Blindness) 01/2018
1	Anemia 01/2016
1	Falciparum Malaria (Plasmodium falciparum Malaria) 01/2012
1	Cerebral Malaria 12/2010
1	Coma (Comas) 12/2010
1	Breast Neoplasms (Breast Cancer) 02/2004

Drug/Important Bio-Agent (IBA)

7	AntigensIBA 01/2023 - 01/2015
6	CytokinesIBA 02/2022 - 09/2008
5	ChemokinesIBA 02/2022 - 07/2013
4	VaccinesIBA 01/2022 - 01/2020
4	Ivermectin (Mectizan)FDA Link 01/2022 - 01/2018
2	Immunoglobulins (Immunoglobulin)IBA 01/2016 - 07/2003
2	ArtesunateIBA 01/2016 - 01/2012
2	AllergensIBA 01/2016 - 01/2015
1	Immunoglobulin G (IgG)IBA 01/2022
1	MitogensIBA 01/2022
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 05/2021
1	1- acetyl- 1,2,3,3a,8,8a- hexahydro- 8a- hydroxy- 5- methoxypyrrolo(2,3- b)indole (CHMI)IBA 01/2021
1	Cytostatic AgentsIBA 02/2018
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2018
1	Drug CombinationsIBA 02/2018
1	Docetaxel (Taxotere)FDA Link 02/2018
1	DNA (Deoxyribonucleic Acid)IBA 01/2018
1	Hemoglobins (Hemoglobin)IBA 01/2016
1	Helminth AntigensIBA 01/2016
1	Interleukin-10 (Interleukin 10)IBA 01/2015
1	Praziquantel (Biltricide)FDA Link 01/2015
1	Interleukin-27 (Interleukin 27)IBA 01/2015
1	AlarminsIBA 01/2015
1	Dermatophagoides AntigensIBA 01/2015
1	Albendazole (Albenza)FDA Link 01/2015
1	Interleukin-33IBA 01/2015
1	Quinine (Quinson)FDA Link 12/2010
1	Pentoxifylline (Trental)FDA LinkGeneric 12/2010
1	LipopolysaccharidesIBA 09/2008
1	Poly CIBA 09/2008
1	LigandsIBA 09/2008
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2008
1	Toll-Like Receptors (Toll-Like Receptor)IBA 09/2008
1	Interferon-gamma (Interferon, gamma)IBA 09/2008
1	Tumor Suppressor Protein p53IBA 02/2004
1	Proteins (Proteins, Gene)FDA Link 07/2003
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2003
1	Peptides (Polypeptides)IBA 07/2003

Therapy/Procedure

3	Mass Drug Administration 01/2022 - 01/2018
3	Therapeutics 01/2020 - 12/2010
1	Chemoprevention 01/2021
1	Mosquito Nets 01/2020